AUTUMN LAMBERT SEARS: Open Payments
NPI 1407564099 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 29 payments from 13 companies in 2025. Trend: 2023 $858 · 2024 $907 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $96 |
| Merck Sharp & Dohme LLC | 4 | $91 |
| Novo Nordisk Inc | 3 | $63 |
| Amgen Inc. | 3 | $52 |
| Medtronic, Inc. | 1 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Lilly USA, LLC | 2 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| BridgeBio Pharma, Inc. | 1 | $25 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $23 |
Products named: JARDIANCE, VERQUVO, REPATHA, SYMPLICITY G3, Wegovy, Assure WCD, Attruby, LifeVest.
Industry payments across OK — which companies pay providers there.
